This article provides an overview of measurable/minimal residual (MRD) testing and its use in treatment planning for ALL, lymphoma and multiple myeloma.
What's New
Lorlatinib (Lorbrena®) is a tyrosine kinase inhibitor (TKI) used in the treatment of progressive, metastatic non small cell lung cancer.
Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer.
Cemiplimab-rwlc (Libtayo®) is a monoclonal antibody used in the treatment of some cases of squamous cell cancer of the skin.
OncoLink Apps
Blogs
OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
View all Blogs
The Great American Smokeout is a Step Towards Becoming Smoke Free!
Each year, on the 3rd Thursday of November, The American Cancer Society marks the Great American Smokeout by encouraging smokers to use the date to make a plan to quit, or to plan in advance and quit smoking that day. To help you in your quest to be smoke free, access our quit smoking resources or learn about the benefits of quitting smoking - even after a cancer diagnosis.
Need Cancer Patient Education Tools?
Our award winning cancer education content is now available for licensing and syndication.
I Wish U Knew!
I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.